<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hechelhammer L</dc:creator>
  <dc:creator>Müllhaupt G</dc:creator>
  <dc:creator>Mordasini L</dc:creator>
  <dc:creator>Markart S</dc:creator>
  <dc:creator>Güsewell S</dc:creator>
  <dc:creator>Betschart P</dc:creator>
  <dc:creator>Schmid HP</dc:creator>
  <dc:creator>Engeler DS</dc:creator>
  <dc:creator>Abt D</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">PURPOSE
To assess the frequency and potential predictors of prostatic central gland tissue detachment (CGD), an enucleation-like reaction that sporadically occurred in a randomized controlled trial assessing efficacy and safety of prostatic artery embolization (PAE).


MATERIALS AND METHODS
Trial data were analyzed to identify patients with CGD after PAE. Clinical parameters, MR imaging findings, technical details of PAE, and periinterventional data were compared between patients with and without CGD to identify parameters for prediction, induction, or early detection of CGD after PAE.


RESULTS
CGD occurred after PAE in 3 of 48 patients (6.3%); these cases had good functional outcomes, but CGD was associated with increased risk of ejaculatory dysfunction and occurrence of complications. Frequency of preoperative transurethral bladder catheterization (100% vs 13.3%; P = .005), central gland index (mean ± standard deviation, 0.86 ± 0.02 vs 0.69 ± 0.14; P &lt; .001), amount of particles applied (1.93 mL ± 0.12 vs 0.96 mL ± 0.36; P &lt; .001), maximum early postoperative pain score (7.33 ± 2.08 vs 1.89 ± 2.40; P = .009), and blood C-reactive protein (CRP) levels after 48 hours (69.0 vs 18.58 mg/dL; P = .045) and 1 week (113.50 vs 5.16 mg/dL; P = .004) were significantly higher in cases of CGD.


CONCLUSIONS
CGD is a rare reaction that might be triggered by prostatic zonal anatomy, embolization technique, and mechanical or inflammatory processes. It should be considered in patients with severe postoperative pain and high CRP levels who experience voiding dysfunction after PAE to avoid complications. Investigation of larger cohorts might further elucidate this tissue response.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/278329</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jvir.2018.09.029</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/30661948</dc:relation>
  <dc:source>Journal of vascular and interventional radiology : JVIR. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Arteries</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Biomarkers</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Biopsy</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">C-Reactive Protein</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cystoscopy</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Embolization, Therapeutic</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Inflammation Mediators</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Magnetic Resonance Imaging</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Necrosis</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Pain, Postoperative</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Prostate</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Prostatic Hyperplasia</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Risk Factors</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Time Factors</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Treatment Outcome</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Urination Disorders</dc:subject>
  <dc:title xmlns:ns21="xml" ns21:lang="en">Predictability and Inducibility of Detachment of Prostatic Central Gland Tissue after Prostatic Artery Embolization: Post Hoc Analysis of a Randomized Controlled Trial.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
